Live feed06:45:00·1973dPRReleasevia QuantisnowLilly, Vir Biotechnology and GSK Announce First Patient Dosed in Expanded BLAZE-4 Trial Evaluating Bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19ByQuantisnow·Wall Street's wire, on your screen.VIR· Vir Biotechnology Inc.GSK· GSK plcLLY· Eli Lilly and CompanyHealth CareOriginal source
